Search
Popular searches:
Mucor
Yeast
Rhizopus arrhizus
Lichtheimia
Rhizopus
Fusarium
Please choose case details first for advanced search.
Reset
Risk Factors
Alcoholism
Autoimmune disease
Burn
Cancer (ALL)
Cancer (AML)
Cancer (CLL)
Cancer (CML)
Cancer (Lymphoma)
Cancer Other
Cancer Other (Other)
Chemotherapy
Chronic cardiovascular disease
Chronic liver disease
Chronic pulmonary disease
Chronic renal disease
Corticosteroids
Diabetes Mellitus
Hematopoietic stem cell transplantation (HSCT)
HIV/AIDS
ICU
IV drug abuse
Major surgery
Neutropenia
Premature birth
Radiotherapy
Solid organ transplantation
Trauma
No risk factors
Site of Infection
Biliary system
Blood
Bone
Bowel
CNS
Eye
Heart
Joint
Kidneys
Liver
Lungs
Paranasal sinuses
Peritoneum
Skin and Deep soft tissue
Spleen
Vessels
CRBSI
Disseminated
Targeted Therapy
Amphotericin B deoxycholate
Amphotericin B lipid complex
Liposomal amphotericin B
Anidulafungin
Caspofungin
Fluconazole
Flucytosine
Isavuconazole
Itraconazole
Micafungin
Posaconazole
Voriconazole
Terbinfine
Olorofim
Ibrexafungerp
Fosmanogepix
Opelconazole
Rezafungin
Other
Final Response
Complete Response
Partial Response
Stable Disease
Progression
Unknown
Usage Distribution Map
Principle Investigator:
Prof. Oliver A. Cornely
, MD, FACP, FIDSA, FAAM, FECMM, Cologne, Germany
Project Manager:
Dr. Danila Seidel
, PhD, FECMM, Cologne, Germany
Coordinating physician:
Dr. Jannik Stemler
, MD, FECMM, MD, Cologne, Germany
Epidemiology & Statistics:
Nico Bekaan
, MD, Cologne, Germany
Imprint
|
Privacy